IBIO, 35c yesterday, hit 61c pre-market 04:41 P
Post# of 148181
04:41 PM EST, 02/03/2020 (MT Newswires) -- iBio (IBIO) said Monday that it has collaborated with Beijing CC-Pharming Ltd to develop and test a new 2019-nCoV vaccine.
The vaccine will be manufactured using iBio's FastPharming System.
The company said the collaboration aims to develop plant-derived vaccine strategies for the emerging coronavirus outbreak.